4.04
Sophia Genetics Sa stock is traded at $4.04, with a volume of 146.14K.
It is down -3.35% in the last 24 hours and up +29.49% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$4.18
Open:
$4.24
24h Volume:
146.14K
Relative Volume:
1.92
Market Cap:
$273.02M
Revenue:
$64.49M
Net Income/Loss:
$-71.40M
P/E Ratio:
-3.7064
EPS:
-1.09
Net Cash Flow:
$-52.00M
1W Performance:
-0.25%
1M Performance:
+29.49%
6M Performance:
+40.28%
1Y Performance:
+15.10%
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SOPH
Sophia Genetics Sa
|
4.04 | 282.48M | 64.49M | -71.40M | -52.00M | -1.09 |
![]()
VEEV
Veeva Systems Inc
|
286.09 | 46.97B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
94.47 | 16.75B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
67.50 | 12.29B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
93.23 | 7.80B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.16 | 6.81B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-18-24 | Initiated | Craig Hallum | Buy |
Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-27-24 | Initiated | Guggenheim | Buy |
Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
Jul-05-23 | Resumed | JP Morgan | Overweight |
Jan-03-23 | Initiated | BTIG Research | Buy |
Nov-23-22 | Initiated | Credit Suisse | Neutral |
Oct-15-21 | Resumed | Cowen | Outperform |
Aug-17-21 | Initiated | Cowen | Outperform |
Aug-17-21 | Initiated | Credit Suisse | Outperform |
Aug-17-21 | Initiated | JP Morgan | Overweight |
Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
Applying big data sentiment scoring on SOPHiA GENETICS SAJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Is SOPHiA GENETICS SA (90B) stock in buy zone after pullbackWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Using flow based indicators on SOPHiA GENETICS SAJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Published on: 2025-10-13 07:16:54 - newser.com
SOPHiA GENETICS SA stock momentum explainedJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Real time scanner hits for SOPHiA GENETICS SA explainedEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
Has SOPHiA GENETICS SA found a price floorJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Pattern recognition hints at SOPHiA GENETICS SA upsideEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView
What catalysts could drive SOPHiA GENETICS SA stock higherMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com
Why SOPHiA GENETICS SA stock is rated strong buy2025 Analyst Calls & Capital Protection Trading Alerts - newser.com
Is SOPHiA GENETICS SA 90B a good long term investmentSupport Level Holds & Rapid Capital Growth - earlytimes.in
Weiss Ratings Reaffirms Sell (D-) Rating for SOPHiA GENETICS (NASDAQ:SOPH) - Defense World
Critical Review: Movano (NASDAQ:MOVE) and SOPHiA GENETICS (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS SA 90B Stock Analysis and ForecastMarket Sentiment Indicators & Register for the Next Free Workshop - earlytimes.in
What data driven models say about SOPHiA GENETICS SA’s futureMarket Movers & Accurate Intraday Trade Tips - newser.com
Can you recover from losses in SOPHiA GENETICS SAJuly 2025 Gainers & Real-Time Buy Zone Alerts - newser.com
Visual analytics tools that track SOPHiA GENETICS SA performanceQuarterly Portfolio Summary & Proven Capital Preservation Tips - newser.com
Momentum divergence signals in SOPHiA GENETICS SA chartMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com
What recovery options are there for SOPHiA GENETICS SAEarnings Risk Report & Weekly Top Stock Performers List - newser.com
How SOPHiA GENETICS SA (90B) stock benefits from digital adoptionWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Is SOPHiA GENETICS SA stock undervalued vs historical averages2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
How to integrate SOPHiA GENETICS SA into portfolio analysis toolsEntry Point & Stepwise Trade Signal Implementation - newser.com
What high frequency data says about SOPHiA GENETICS SAMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com
What drives SOPHiA GENETICS SA 90B stock priceDebt-to-Equity Ratio Analysis & Low Risk Trading Ideas - earlytimes.in
SOPHiA GENETICS SA Trends on Nasdaq 100 Index Performance - Kalkine Media
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores - Benzinga
How SOPHiA GENETICS SA (90B) stock behaves in tightening cyclesMarket Activity Summary & Capital Efficiency Focused Strategies - newser.com
Is now a turning point for SOPHiA GENETICS SAMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Can machine learning forecast SOPHiA GENETICS SA recoveryStop Loss & Low Drawdown Investment Strategies - newser.com
Can SOPHiA GENETICS SA recover in the next quarterExit Point & AI Driven Price Predictions - newser.com
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):